We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Cytori Receives Cell-Enriched Fat Grafting Patent in Japan
Product News

Cytori Receives Cell-Enriched Fat Grafting Patent in Japan

Cytori Receives Cell-Enriched Fat Grafting Patent in Japan
Product News

Cytori Receives Cell-Enriched Fat Grafting Patent in Japan


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Cytori Receives Cell-Enriched Fat Grafting Patent in Japan"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Cytori Therapeutics has received Japanese Patent No. 4722041 (the '041 patent) covering the preparation of adipose-derived stem and regenerative cell (ADRC) enriched fat grafts using any closed system, such as Cytori's Celution® System.

The patent specifically protects the Company's cell-enriched fat grafting applications in Japan including breast reconstruction and other soft tissue defects, urinary incontinence and multiple cosmetic uses.

Cell-enriched fat grafting is the process of enriching the patient's own fat tissue with their own stem and regenerative cells primarily for use in reconstructive and cosmetic procedures. Fat is taken from the patient's stomach, hips, thighs, or other areas, by liposuction.

Some of the tissue is used to extract the patient's own stem and regenerative cells which occur naturally inside the tissue. The extracted cells are then combined with some of the patient's own fat tissue, which forms a cell-enriched fat graft that is injected into the desired area.

This is Cytori's second patent to be issued in Japan, in addition to Patent No. 4653952 covering devices for extracting and concentrating stem and regenerative cells from adipose tissue issued in February 2011. Cytori's Japanese patents are a part of Cytori's global intellectual property portfolio, including 34 issued patents and more than 100 pending applications.

Advertisement